<p>Indian shares climbed to record highs on Tuesday, led by sharp gains in heavyweight Reliance Industries and top automaker Maruti Suzuki, as hopes for a coronavirus vaccine supported risk sentiment.</p>.<p>The NSE Nifty 50 index rose 0.46 per cent to 13,416.8 by 0444 GMT and looked set to extend gains for a sixth day, while the benchmark S&P BSE Sensex was up 0.53 per cent at 45,668.37.</p>.<p>India, the second-worst affected country by the pandemic, is accelerating its review of Covid-19 vaccines developed by Pfizer Inc and AstraZeneca to authorise for emergency use, a senior official said on Monday.</p>.<p>The country reported 26,567 new coronavirus infections, data from the health ministry showed on Tuesday, the lowest daily increase since July 10, according to a Reuters tally.</p>.<p>The main stock indexes have gained nearly 3 per cent so far in December, as of their last close, having hit record highs in 13 of the last 20 sessions.</p>.<p>"Liquidity flow is extremely strong and I don't see that going away anytime soon, given that money being pumped into the economy by the United States and the UK will find its way into the market," said Samrat Dasgupta, CEO at Esquire Capital Investment Advisors.</p>.<p>India's most valuable firm Reliance Industries Ltd jumped 2.9 per cent to its highest since mid-November, while Maruti Suzuki India Ltd climbed 3.5 per cent to a more than two-year high, boosting the Nifty Auto Index by 1.5 per cent.</p>.<p>State-run Canara Bank Ltd surged 7.7 per cent as it launched a qualified institutional placement of shares to raise 20 billion rupees ($270.93 million).</p>.<p>Meanwhile, Asian shares slipped after overnight pressure on Wall Street as investors fretted over the impact of a new round of COVID-19 restrictions in some U.S. states, with the focus fixed on a new stimulus package for the world's largest economy.</p>
<p>Indian shares climbed to record highs on Tuesday, led by sharp gains in heavyweight Reliance Industries and top automaker Maruti Suzuki, as hopes for a coronavirus vaccine supported risk sentiment.</p>.<p>The NSE Nifty 50 index rose 0.46 per cent to 13,416.8 by 0444 GMT and looked set to extend gains for a sixth day, while the benchmark S&P BSE Sensex was up 0.53 per cent at 45,668.37.</p>.<p>India, the second-worst affected country by the pandemic, is accelerating its review of Covid-19 vaccines developed by Pfizer Inc and AstraZeneca to authorise for emergency use, a senior official said on Monday.</p>.<p>The country reported 26,567 new coronavirus infections, data from the health ministry showed on Tuesday, the lowest daily increase since July 10, according to a Reuters tally.</p>.<p>The main stock indexes have gained nearly 3 per cent so far in December, as of their last close, having hit record highs in 13 of the last 20 sessions.</p>.<p>"Liquidity flow is extremely strong and I don't see that going away anytime soon, given that money being pumped into the economy by the United States and the UK will find its way into the market," said Samrat Dasgupta, CEO at Esquire Capital Investment Advisors.</p>.<p>India's most valuable firm Reliance Industries Ltd jumped 2.9 per cent to its highest since mid-November, while Maruti Suzuki India Ltd climbed 3.5 per cent to a more than two-year high, boosting the Nifty Auto Index by 1.5 per cent.</p>.<p>State-run Canara Bank Ltd surged 7.7 per cent as it launched a qualified institutional placement of shares to raise 20 billion rupees ($270.93 million).</p>.<p>Meanwhile, Asian shares slipped after overnight pressure on Wall Street as investors fretted over the impact of a new round of COVID-19 restrictions in some U.S. states, with the focus fixed on a new stimulus package for the world's largest economy.</p>